ClinicalTrials.gg
Not yet recruitingNCT07425470Updated Feb 20, 2026

SCI Epidemiology and Complications

An observational study in Spinal Cord Injury, sponsored by Bandırma Onyedi Eylül University. Not yet recruiting at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2026-02-20.

Sponsored by Bandırma Onyedi Eylül University · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
50
Sex
All
01

Study summary

The aim of this study was to epidemiologically evaluate patients diagnosed with spinal cord injury who were admitted to our clinic over the last five years and, unlike similar studies, to investigate the presence of complications in these patients. The investigators hope that this study will contribute to the literature by raising awareness of spinal cord injury epidemiology and potential complications.

Read the detailed description

This study was designed as a retrospective descriptive study. Patients who were admitted to the Physical Medicine and Rehabilitation outpatient clinic of Bandırma Training and Research Hospital with a diagnosis of paraplegia or tetraplegia between December 1, 2020, and December 1, 2025, were included in the study. These diagnoses were screened using the following ICD-10 codes: G82 (paraplegia and tetraplegia), G82.0 (flaccid paraplegia), G82.1 (spastic paraplegia), G82.2 (paraparesis and paraplegia, unspecified), G82.3 (flaccid tetraplegia), G82.4 (spastic tetraplegia), and G82.5 (tetraplegia, unspecified).

Data regarding patients' age, sex, etiology of spinal cord injury, level of injury, and the presence of complications were recorded. In cases where complications were present, the time from injury to the development of complications was recorded in months.

Since the most common causes of spinal cord injury differ across age groups, age categories were defined as ≤29 years, 30-44 years, 45-59 years, 60-74 years, and ≥75 years. Etiological classification was based on the most common causes reported in the literature, including traffic accidents, falls from height, sports-related injuries, post-disc herniation or surgery, non-traumatic/inflammatory causes, and other causes.

As the level of injury affects both clinical presentation and the development of complications, injury levels were categorized as cervical (C1-C8), thoracic (T1-T12), and lumbosacral (L1-S5). Evaluation parameters and grouping methods were determined based on similar studies reported in the literature.

02

Conditions studied

  • Spinal Cord Injury

Keywords

  • spinal cord injuries
  • complications
  • paraplegia
  • tetraplegia
03

In context

Spinal Cord Injuries

2,025 studies on the registry are indexed under Spinal Cord Injuries; 537 are open to participants now.

This study's planned enrollment of 50 is below the median of 60 across 332 observational studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Bandırma Onyedi Eylül University is the lead sponsor of 70 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients who presented to our hospital's Physical Medicine and Rehabilitation outpatient clinic with diagnoses of paraplegia and tetraplegia between December 1, 2020, and December 1, 2025.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • clinical diagnosis of paraplegia
  • clinical diagnosis of tetraplegia

Exclusion criteria

Exclusion Criteria:

  • traumatic brain injury
  • brain tumor
  • cranial lesions
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients who presented to our clinic with SCI between December 1, 2020, and December 1, 2025

    Patients who presented to our hospital's Physical Medicine and Rehabilitation outpatient clinic with diagnoses of paraplegia and tetraplegia between December 1, 2020, and December 1, 2025.

    Other: Retrospective data analysis

Interventions

  • OtherRetrospective data analysis

    Patient data regarding age, gender, etiology of spinal cord injury, level of injury, and whether complications develop will be recorded.

06

What researchers measure

Primary outcomes

  1. Average age and gender of patients followed up in our clinic due to spinal cord injury

    -Average age and gender of patients followed up in our clinic due to spinal cord injury

    Time frame: 1 month

  2. Etiology of injury in patients followed up in our clinic due to spinal cord injury

    Etiology of injury in patients followed up in our clinic due to spinal cord injury 1. Traffic accident 2. Fall from a height 3. Sports injuries 4. Disc herniation/post-surgery 5. Non-traumatic causes/Inflammatory causes 6. Other causes

    Time frame: 1 month

  3. Stage of injury in patients followed up in our clinic due to spinal cord injury

    -Stage of injury in patients followed up in our clinic due to spinal cord injury 1. C1-C8 2. T1-T12 3. L1-S5

    Time frame: 1 month

  4. Whether or not complications developed in patients followed up in our clinic due to spinal cord injury

    -Whether or not complications developed in patients followed up in our clinic due to spinal cord injury These complications include: Pressure ulcer, Urinary tract infection, Deep vein thrombosis, Joint contracture, Osteoporosis/fracture, Spasticity, Autonomic dysreflexia, Psychological problems, Sexual problems, Charcot joint, Urethral stricture, Post-traumatic syringomyelia, Heterotopic ossification, Other systemic problems (respiratory problems, cardiac problems, gastrointestinal problems, metabolic and endocrine problems).

    Time frame: 1 month

Secondary outcomes

  1. the time when the complication developed

    \- In patients followed up in our clinic due to spinal cord injury who developed complications, the time when the complication developed.

    Time frame: 1 month

07

Study locations

1 site
  • Bandırma Onyedi Eylul University Faculty of Medicine
    Balıkesir, Bandırma 10200, Turkey (Türkiye)
    • Ayşe Güldem Kilciler, Prof. · Contactakilciler@bandirma.edu.tr · +9 0266 717 01 17
    • Nurten Nas Kırdar, Assistant Professor · Principal investigator
08

References and documents

Publications

  • Josefson C, Rekand T, Lundgren-Nilsson A, Sunnerhagen KS. Epidemiology of Spinal Cord Injury in Adults in Sweden, 2016-2020: A Retrospective Registry-Based Study. Neuroepidemiology. 2025;59(4):334-342. doi: 10.1159/000540818. Epub 2024 Aug 13. PubMed 39137737 ↗
  • Bombardier CH, Lee DC, Tan DL, Barber JK, Hoffman JM. Comorbid Traumatic Brain Injury and Spinal Cord Injury: Screening Validity and Effect on Outcomes. Arch Phys Med Rehabil. 2016 Oct;97(10):1628-34. doi: 10.1016/j.apmr.2016.03.008. Epub 2016 Apr 12. PubMed 27084266 ↗

Individual participant data

Plan to share: No — If the results of our study are deemed suitable for publication in an appropriate journal after peer review, they will be accessible to all researchers once published.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07425470
Lead sponsor
Bandırma Onyedi Eylül University
Responsible party
Nurten NAS KIRDAR (Assistant Professor, Bandırma Onyedi Eylül University) — Principal investigator
First posted
Feb 20, 2026
Start date
Mar 1, 2026 (estimated)
Primary completion
Mar 31, 2026 (estimated)
Completion
Apr 10, 2026 (estimated)
Last update
Feb 20, 2026

Study contacts

Nurten NAS KIRDAR, Assistant Professor
Contact
nkirdar@bandirma.edu.tr
+905415511691
Naime Meriç KONAR EROL, Associate Professor
Contact
mkonar@bandirma.edu.tr
Nurten Nas Kırdar, Assistant Professor
principal investigator · Bandırma Onyedi Eylül University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion